Precision Medicine Blood Test Can ID Those who Will Respond to FDA-Approved Treatment
New research has uncovered a precision medicine test to identify a patient subgroup of a rare blood disorder who are more likely to respond to treatment.
Read MorePosted by Chris Wolski | Sep 3, 2021 | Disease States |
New research has uncovered a precision medicine test to identify a patient subgroup of a rare blood disorder who are more likely to respond to treatment.
Read MorePosted by Chris Wolski | Sep 3, 2021 | Molecular Diagnostic Analyzers |
The GENFLEX Molecular System is a high-throughput, automated, and scalable instrument for processing SARS-CoV-2 molecular diagnostic tests.
Read MorePosted by Chris Wolski | Sep 3, 2021 | Pipette Tips |
Thermo Fisher Scientific has announced a $192.5 million contract award from the U.S. DoD to ensure reliable domestic production of pipette tips.
Read MorePosted by Chris Wolski | Sep 3, 2021 | Covid 19, POC Rapid Assays |
LumiraDx announced the U.S. launch of its COVID-19 Surveillance Test, for environments such as schools and workplaces.
Read MorePosted by Chris Wolski | Sep 2, 2021 | Covid 19 |
Rapid saliva tests contributed to low COVID transmission among students, teachers, and staff in the the Special School District of St. Louis County.
Read More